Brief: Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter And Full Year 2025 Revenue Results
12/01/2026 13:44
Jan 12 (Reuters) - Apyx Medical Corp APYX.O: ORATION REPORTS PRELIMINARY, UNAUDITED, FOURTH QUARTER AND FULL YEAR 2025 REVENUE RESULTS Q4 REVENUE EXPECTED BETWEEN $19.0-$19.2 MILLION, UP 34% YOY Q4 REVENUE VIEW $17.4 MILLION -- LSEG IBES DATA Source text: ID:nGNX39sZPl Further company coverage: APYX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength